Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELETRIPTAN HYDROBROMIDE vs ELOSULFASE ALFA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELETRIPTAN HYDROBROMIDE vs ELOSULFASE ALFA: Safety Overview

Metric ELETRIPTAN HYDROBROMIDE ELOSULFASE ALFA
Total FAERS Reports 2,158 5,024
Deaths Reported 12 118
Death Rate 0.6% 2.3%
Hospitalizations 271 1,056
Average Patient Age 52.6 yrs 17.4 yrs
% Female Patients 86.2% 56.7%
FDA Approval Date Aug 11, 2017 N/A
Manufacturer Zydus Pharmaceuticals USA Inc. BioMarin Pharmaceutical Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription